过去一年中添加的文章,按日期排序

대한갑상선학회갑상선분화암진료권고안; Part I. 갑상선분화암의초기치료-제5 장갑상선분화암의수술후초기질병상태와재발위험도평가및초기위험군분류2024

이은경, 송영신, 강호철, 김선욱, 나동규… - International Journal …, 2024 - kiss.kstudy.com
3 天前 - … , genetic mutations, and vascular invasion in follicular cancer, … combining
encapsulated follicular variant papillary thyroid cancer, follicular thyroid cancer, and oncocytic thyroid

[HTML][HTML] Targeted sequencing of DNA/RNA combined with radiomics predicts lymph node metastasis of papillary thyroid carcinoma

R Zhang, L Hu, Y Cheng, L Chang… - Cancer …, 2024 - cancerimagingjournal.biomedcentral …
5 天前 - … risk in patients with thyroid carcinoma have been proposed … of thyroid carcinoma
on the basis of a combination of … by comparing mutations and fusions between cancer tissues …

NEOADJUVANT TREATMENT WITH LENVATINIB AND PEMBROLIZUMAB IN A BRAF V600E MUTATED ANAPLASTIC THYROID CANCER: CASE REPORT

D Barbaro, R Forleo, M Profilo, P Lapi, C Giani… - Frontiers in … - frontiersin.org
8 天前 - … The histology confirmed papillary thyroid cancer (PTC) in the left … BRAF V600E
mutation was present in both PTC and in … Conclusion: L and P in combination also appear to be …

Multifocal Papillary Thyroid Carcinomas With Discordant Molecular Drivers: Emphasizing the Morphology and Collision Tumors

JP Rivera, YC Yeh, PCH Chen… - The American Journal of …, 2024 - journals.lww.com
22 天前 - … most common combination being BRAF and RAS mutations.… patterned tumors with
RAS mutations can now be clas… ) mutational status in multifocal papillary thyroid carcinoma

Interim analysis of ABM-1310, a blood-brain barrier-penetrant BRAF inhibitor, in patients with BRAF V600-mutated solid tumors.

SA Piha-Paul, MI De La Fuente, F Iwamoto, S Nagpal… - 2024 - ascopubs.org
24 天前 - … n=2, papillary thyroid carcinoma [PTC] n=1, and pancreatic cancer [PC] n=1). Eleven
pts … The MTD for ABM-1310 either as monotherapy or in combination with cobimetinib was …

Impact of molecular therapy on radioactive iodine uptake in patients with oncogene-driven metastatic differentiated thyroid cancer.

AT Yang, B Segers, O Caradonio, S Behl, Y Li… - 2024 - ascopubs.org
24 天前 - mutations are common in pediatric and young adult patients with papillary thyroid
cancer … who achieve a complete response to the combination of targeted therapy and RAI. …

Application value of multi-gene mutation detection in the clinical management of pediatric papillary thyroid carcinoma: a preliminary exploration

Y Wang, H Wang, G Tan, X Wu, B Wang… - Frontiers in …, 2024 - frontiersin.org
31 天前 - … one or combination of … mutations rates in 22 studies of thyroid cancer in children.
(B) The molecular variability rates of BRAF V600E, RET rearrangement, and RAS mutations in …

Thyroid papillary carcinoma combined with primary follicular lymphoma: a case report

T Xu, L Wu, H Ye, S Luo, J Wang - Diagnostic Pathology, 2024 - Springer
32 天前 - Papillary thyroid carcinoma (PTC) stands out as the most prevalent epithelial malignant
thyroid tumor… case of PTC combined with PFL featuring an EZH2 gene mutation, which …

… College of Radiology Thyroid Imaging Reporting and Data System and clinicopathological characteristics in pediatric patients with papillary thyroid carcinoma

Y Tan, J Zhong, T Zheng, Y Fu, M Liu, G Wang - Pediatric Radiology, 2024 - Springer
33 天前 - … , BRAF V600E mutation was … mutation and nodule size, composition, shape, margin,
cervical lymph node metastasis, or Hashimoto’s thyroiditis (P-value> 0.05). Combined with …

Columnar Cell Thyroid Carcinoma: A Heterogeneous Entity Demonstrating Overlap Between Papillary Thyroid Carcinoma and Follicular Neoplasms

KE Higgins, PM Sadow, DN Johnson, P Wang… - Head and Neck …, 2024 - Springer
43 天前 - … All cases had mixed papillary and follicular growth patterns. All cases contained
areas of … This particular ATM missense mutation has not previously been reported in thyroid